A Pilot RCT on the Management of Term Prelabour Rupture of Membranes
"Active vs Expectant Management and Routine vs Only-when-necessary Vaginal Examinations During Labour for Prelabour Rupture of Membranes at Term, a Pilot RCT Study"
2 other identifiers
interventional
120
1 country
1
Brief Summary
This is a pilot study that will eventually result in a main randomised controlled trial that will look at what management is associated with a higher rate of normal birth and a lower rate of chorioamnionitis (maternal infection) when women break their waters but labour does not start. Spontaneous rupture of the membranes (when the waters break) at term (37-42 weeks gestation) is a physiological event that happens during labour. However, according to Gunn et al. (1970) in 8-10 % of the cases the membranes rupture before labour starts. The time between the rupture and the onset of labour is called latent phase and time wise is variable. Studies have showed no statistically significant differences in terms of neonatal infection or chorioamnionitis when the investigators induce labour with prostaglandins compared to when labour starts spontaneously (Hannah et al 1996). Seaward et al. (1997) noted a number of confounding factors that might relate to the incidence of chorioamnionitis (maternal infection), the strongest predictor was having more than 8 vaginal examinations since the rupture of membranes and before delivery which was a stronger predictor than the duration of the latent phase. It is thought that by reducing the number of internal examinations, chorioamnionitis may be reduced, and hence neonatal infection may also be reduced. The main RCT will compare clinical outcomes and maternal satisfaction when women consent to be randomized to four groups: (1) Active management and routine internal examinations during labour, (2) Active management and reduced internal examinations, (3) Expectant management and routine internal examinations, (4) Expectant management and reduced internal examinations. This application seeks ethics approval for the pilot phase to ensure that a definitive study can be undertaken appropriately. It is important to test that all the components work well individually and as a whole, to estimate sample size and ultimately to test the integrity of the research protocol before embarking on the main trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 14, 2016
CompletedFirst Posted
Study publicly available on registry
August 19, 2016
CompletedStudy Start
First participant enrolled
November 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2017
CompletedNovember 16, 2016
November 1, 2016
11 months
July 14, 2016
November 14, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of eligible women who agree to take part in the study
12 months during pilot stage
Secondary Outcomes (2)
Percentage of participants who stay in the allocation arm
12 months during pilot stage
Percentage of participants who find the interventions acceptable
The questionnaire will be completed by the participants between 4-8 weeks after giving birth
Study Arms (4)
Expectant management and minimal vaginal examinations
EXPERIMENTALExpectant management up to approximately 96hours and vaginal examinations only when necessary during active labour
Expectant management and routine vaginal examinations
EXPERIMENTALExpectant management up to approximately 96hours and routine vaginal examinations during active labour
Active management and minimal vaginal examinations
EXPERIMENTALInduction of labour at approximately 24hours and vaginal examinations only when necessary during active labour
Active management and routine vaginal examinations
ACTIVE COMPARATORInduction of labour at approximately 24hours and routine vaginal examinations
Interventions
Eligibility Criteria
You may qualify if:
- Prelabour rupture of membranes (confirmed)
- Term pregnancy - from 37+0 till 41+2 weeks gestation (both inclusive)
- Normal/Low risk pregnancy
- Singleton, cephalic pregnancy
- No known current infectious diseases
- Aged 18-45 years old
- Understands English and is able to read and write in English
- Agree for their placentas to be sent to histology if clinical signs of infection
- Not taking part in other clinical research at present
- Consent to take part
You may not qualify if:
- Pregnancy of 36+6 or less or 41+3 or more weeks gestation
- Breech or oblique presentation
- Twin or multiple pregnancy
- Previous caesarean section
- Meconium stained liquor
- Pre-eclampsia
- Diabetes
- Known to be colonised by Group B streptococcus
- Current infections: HIV, Hepatitis B, Herpes
- Doesn't give consent for the placenta to be sent to histology if clinical signs of infection
- Not able to understand, read or write in English
- Currently taking part in other clinical research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lancashire Teaching Hospitals NHS Trust
Preston, Lancashire, United Kingdom
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lucia Ramirez-Montesinos, MSc BSc
University of Central Lancashire
- STUDY DIRECTOR
Soo Downe, PhD MSc BSc
University of Central Lancashire
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Miss
Study Record Dates
First Submitted
July 14, 2016
First Posted
August 19, 2016
Study Start
November 1, 2016
Primary Completion
October 1, 2017
Study Completion
November 1, 2017
Last Updated
November 16, 2016
Record last verified: 2016-11
Data Sharing
- IPD Sharing
- Will not share